
Morgan Stanley initates Recursion Pharmaceuticals Inc (RXRX) rating to an Equal-weight
Recursion Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.84 million
Recursion Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.84 million
Recursion Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.84 million
In a filing, Recursion Pharmaceuticals Inc revealed its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.84 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Recursion Pharmaceuticals Inc revealed its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.84 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Recursion Pharmaceuticals